Track this trial free. DataLookout checks ClinicalTrials.gov daily and emails you which fields changed on NCT04159662 (status, enrollment, completion dates, endpoints, sites) when this record is updated. Free accounts track up to 5 trials.

Track this trial

Brain Imaging of Cognition Inn Schizophrenia and Depression

StatusRecruiting
PhaseNot specified
Started
View on ClinicalTrials.gov ↗
Record status
This record was last updated March 23, 2026 (before its estimated October 1, 2026 completion). Its status may not reflect the trial's current state.

Record History

  1. Primary endpoints: 2 to 1 Eligibility criteria expanded, about 67 words · Secondary endpoints shortened, about 15 words · Study description shortened, about 31 wordsv6 Show 3 more changesShow less
    • Eligibility criteria expanded, about 67 words
    • Secondary endpoints shortened, about 15 words
    • Study description shortened, about 31 words

    See this version in full on ClinicalTrials.gov ↗

  2. Phase: Not applicable to Not specified Enrollment target: 96 to 90 · Interventions: Active Control Intervention (Behavioral), Cognitive Intervention (Behavioral) to not stated · Eligibility criteria revised · 3 morev5 Show 6 more changesShow less
    • Enrollment target: 96 to 90
    • Interventions: Active Control Intervention (Behavioral), Cognitive Intervention (Behavioral) to not stated
    • Eligibility criteria revised
    • Study description expanded, about 125 words
    • Study arms: 2 to 3
    • Study title expanded, about 2 words

    See this version in full on ClinicalTrials.gov ↗

  3. Primary and study completion dates: Nov 2022 to Oct 1, 2026v4
  4. Re-verified, no change to tracked fieldsv3
  5. Trial status: Not Yet Recruiting to Recruiting Study sites: 0 to 1 · Start date changed from estimate of Nov 2019 to Dec 12, 2019v2 Show 2 more changesShow less
    • Study sites: 0 to 1
    • Start date changed from estimate of Nov 2019 to Dec 12, 2019
  6. Study First Submitted
  • Stopped: an ongoing trial was terminated, suspended or withdrawn.
  • Notable: the trial’s plan changed such as a big move in its timeline or size, a new primary endpoint, sponsor or phase, or recruiting opened or resumed.
  • Minor: routine progress and housekeeping, such as sites added or enrollment closed.
Schizophrenia and depression are among the most disabling disorders in all of medicine. Cognitive deficits play a key role in patients' disability, affecting their capacity to contribute actively to society by sustaining employment or academic activity. Moreover, cognitive difficulties tend to persist even after the stabilization of other clinical symptoms. Verbal memory and emotion regulation are two important cognitive domains that are impaired in schizophrenia and depression and are associated with patients' functional outcomes. In this study, brain imaging is used to investigate the brain mechanisms underlying these cognitive deficits in these populations.
Trial Details
NCT Number NCT04159662
Lead Sponsor The Royal Ottawa Mental Health Centre
Conditions Schizophrenia / Schizoaffective Disorder, Depression / Major Depressive Disorder
Enrollment 90 participants
Start Date
Primary Completion (estimated)
Study Completion (estimated)
Updated on ClinicalTrials.gov